CXCL13 and viral pneumonia: Other cytokines such as IL‐8, IL‐6, interferon‐γ, CXCL10 and CXCL13 may be impacted by ozanimod, which aligns with the ability of S1P1 modulators to decrease inflammatory cytokines during viral pneumonia as seen in preclinical models.6